PPARA and metabolic dysfunction-associated steatohepatitis: MIR21 also decreases the expression of PPARA in NASH, however, activated PPARα by MIR21 suppression reduces inflammation, liver injury, and fibrosis without improvement in FA β-oxidation and lipid accumulation (Loyer et al., 2016).